Idiopathic Oxalate Nephropathy Leading to End-Stage Kidney Disease: A Case Report

被引：0

作者：

Saleem, Maryam ^{[1
,2
,3
]}

Shahjahan, Khadija ^{[4
]}

Iftikhar, Hassaan ^{[1
,5
,6
]}

机构：

[1] Ohio Valley Nephrol Associates, Nephrol, Owensboro, KY 42303 USA

[2] Washington Univ, Sch Med, Nephrol, St Louis, MO 63130 USA

[3] Waterbury Hosp & Hlth Ctr, Internal Med, Waterbury, CT 06708 USA

[4] Faisalabad Med Univ, Internal Med, Faisalabad, Pakistan

[5] Washington Univ, Sch Med, Nephrol, St Louis, MO USA

[6] St Francis Med Ctr, Internal Med, Trenton, NJ USA

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 07期

关键词：

end stage kidney disease (eskd); idiopathic hyperoxaluria; primary hyperoxaluria; oxalate nephropathy; aki; MANAGEMENT; MECHANISMS;

D O I：

10.7759/cureus.42402

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Oxalate nephropathy represents a frequently overlooked etiology of renal failure, characterized by the deposition of calcium oxalate crystals within the renal parenchyma. This progressive form of kidney disease is marked by a significant increase in serum creatinine (Cr) level accompanied by evidence of oxalate crystal deposition on renal biopsy causing tubular obstruction and tubular injury leading to fibrosis. In all instances of oxalate nephropathy, examination of stones consistently exhibits multiple birefringent calcium oxalate crystals under polarized light. This case report details the clinical course of a patient who initially presented with progressively worsening renal function and ultimately developed end-stage kidney disease (ESKD) as a consequence of idiopathic hyperoxaluria.

引用

页数：4

共 50 条

[1] TacrolimusDeterioration of acute kidney injury leading to end-stage renal disease: case report
[J]. Reactions Weekly, 2020, 1792 (1) : 214 - 214
[2] Ascorbic acid/cefoperazone/cisplatinAute kidney injury due to calcium oxalate nephropathy with a progression to end-stage renal disease: case report
[J]. Reactions Weekly, 2017, 1656 (1) : 68 - 68
[3] AdalimumabInterstitial nephritis and end-stage kidney disease: case report
[J]. Reactions Weekly, 2018, 1719 (1) : 17 - 17
[4] Antineoplastics/tacrolimusWorsening of end-stage kidney disease and liver disease leading to end-stage kidney disease requiring dialysis and acute liver failure, and impaired renal function: case report
[J]. Reactions Weekly, 2020, 1831 (1) : 53 - 53
[5] PLASMA OXALATE VALUES IN PATIENTS WITH END-STAGE KIDNEY DISEASE
Metry, Elisabeth
Garrelfs, Sander
Bijlsma, Joost
Neradova, Aegida
Vaz, Fred
Oosterveld, Michiel
Groothoff, Jaap
[J]. PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3358 - 3358
[6] PLASMA OXALATE VALUES IN PATIENTS WITH END-STAGE KIDNEY DISEASE
Metry, Ella
Garrelfs, Sander
Oosterveld, Michiel
Neradova, Aegida
Bijlsma, Joost
Vaz, Fred
Groothoff, Jaap
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
[7] IgA nephropathy in a laboratory worker that progressed to end-stage renal disease: a case report
Min, Bokki
Kim, Gyuree
Kang, Taesun
Yoon, Chungsik
Cho, Sung-il
Paek, Domyung
[J]. ANNALS OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2016, 28
[8] CidofovirAcute kidney injury progressing to end-stage renal disease: case report
[J]. Reactions Weekly, 2014, 1522 (1) : 64 - 64
[9] END-STAGE KIDNEY AND ACQUIRED MULTICYSTIC RENAL-DISEASE - REPORT OF A CASE
CALLEJA, C
MADRIGAL, LS
[J]. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1982, 34 (02): : 169 - 173
[10] MethotrexateVarious toxicities in an elderly patient with end-stage kidney disease: case report
[J]. Reactions Weekly, 2007, 1134 (1) : 18 - 18

← 1 2 3 4 5 →